Did you know there is a cost associated with Atopic Dermatitis?
Sanofi commissioned think tank Demos to analyse the impact that uncontrolled eczema has on people with atopic eczema, the health service, and the wider economy. The Costs of Atopic Dermatitis Report found that people with uncontrolled eczema face hidden costs, for example things such as medicines, cosmetics, and household essentials like laundry powder. Patients experience intangible costs too, as the condition impacts their social life and mental health. It also examines the financial and rescource burden that atopic eczema places on the economy and the HS - a burden that is borne by everyone in the UK.
- Medication costs make up the bulk of atopic dermatitis (AD) patients' medical costs; they spend on average an additional £24.45 (€27.63) on emollients and moisturisers and £15.70 (€17.74) a month on medication1.
- The direct cost of uncontrolled eczema to the health service was estimated at being £257 million in 20201.
- In the UK, the indirect costs of work impairment to the economy for adult patients with moderate-to-severe AD is estimated to be between £6,741 - £14,166 per patient, per year1.
- It is estimated that around 15 - 20% of GPs' workload is dermatology, with a large quantity of that work being eczema1.
Read the full report
Read the full report and find out more about the cost of living with Atopic Dermatitis.
Date of preparation: September 2023